NasdaqGM - Nasdaq Real Time Price
USD
Scribe Therapeutics Inc. (SCTX)
14.70
-0.72
(-4.67%)
As of 9:50:12 AM EST. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
|
Purchases
|
0 | 0 |
|
Sales
|
-- | 0 |
|
Net Shares Purchased (Sold)
|
0 | 0 |
|
Total Insider Shares Held
|
3.41M | -- |
|
% Net Shares Purchased (Sold)
|
-- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | 11,478,879 |
| % Change in Institutional Shares Held | 100.00% |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| AGHAZADEH BEHZAD PH.D. Director and Beneficial Owner of more than 10% of a Class of Security |
Purchase at price 18.25 - 22.31 per share. | Indirect | 51,776,426 | Jul 28, 2026 |
| GORDON CARL L Director |
Purchase at price 18.97 per share. | Indirect | 18,970,000 | Jul 27, 2026 |
| GORDON CARL L Director |
-- | Indirect | -- | Jul 27, 2026 |
| ORBIMED ADVISORS, L.L.C. Director |
Purchase at price 18.97 per share. | Indirect | 18,970,000 | Jul 27, 2026 |
| ORBIMED ADVISORS, L.L.C. Director |
-- | Indirect | -- | Jul 27, 2026 |
| DOUDNA JENNIFER A. PH.D. Beneficial Owner of more than 10% of a Class of Security |
-- | Direct | -- | Jul 27, 2026 |
| AH BIO FUND II LP Beneficial Owner of more than 10% of a Class of Security |
Purchase at price 18.97 per share. | Indirect | 6,323,327 | Jul 27, 2026 |
| AH BIO FUND II LP Beneficial Owner of more than 10% of a Class of Security |
-- | Indirect | -- | Jul 27, 2026 |
| LUCAS SVETLANA Officer |
Purchase at price 15.00 per share. | Indirect | 45,000 | Jul 23, 2026 |
| PARROT DAVID L. Chief Financial Officer |
Purchase at price 15.00 per share. | Indirect | 39,990 | Jul 23, 2026 |
